Pharmaceutical giant AstraZeneca is not in talks over a deal with rival Bristol Myers Squibb, according to information provided to Reuters. Earlier this week, the Financial Times reported that the pharmaceutical giants were discussing a merger.
BusinessThe Stockholm Stock Exchange started the trading day clearly higher, but then turned sour. At the close, the broad OMXS index had fallen 0.1 percent.
BusinessThe Stockholm Stock Exchange started the trading week with a clear rise. At the close, the OMXS index was up 0.8 percent. AstraZeneca went against the grain and sank on merger rumors.
BusinessPharmaceutical giant AstraZeneca is discussing a merger with American competitor Bristol Myers Squibb, according to the Financial Times. AstraZeneca's share price is plunging on the Stockholm Stock Exchange. It doesn't fit neatly into the business dynamics, says Johan Unnerus, pharmaceutical analyst at SB1 Markets.
BusinessYou're up to date in Bristol Myers Squibb
That's every story in Bristol Myers Squibb for now.
